Clinical Trials

Clinical Trial Detail

Return to search results.

Palliative Care Support for Patients With Hematological Malignancies Undergoing Hematopoietic Cell Transplant

Complete title: Feasibility of Implementing Pre-Transplant Evaluation by the Supportive Care Team for Patients Undergoing Hematopoietic Cell Transplantation for Hematological Malignancies

Research Study Number       2659.00
Principal Investigator       Stephanie Lee, MD, MPH
Phase       Pilot

Look up trial at NIH

Research Study Description

This pilot clinical trial studies supportive care for patients with hematological malignancies undergoing hematopoietic cell transplant. Supportive care may improve quality of life in this patient population.

Eligibility Criteria (must meet the following to participate in this study)

Ages Eligible for Study: 18 Years and older

Genders Eligible for Study: Both

- Written informed consent

- English as primary language

- Planned autologous or allogeneic hematopoietic cell transplantation

- Presence of co-morbidities (hematopoietic cell transplant co-morbidity index [HCT-CI] score 3 or greater), high risk disease (relapse risk > 25%), or a planned type of transplant (human leukocyte antigen [HLA]-mismatched allogeneic or myeloablative) that places the patient at a higher than average risk of non-relapse mortality or relapse

Other eligibility criteria may apply.

Exclusions (conditions that would prevent participation in this study)

- Major psychiatric diagnosis that impairs cognitive functioning or is not controlled at the time of the approach, as judged by the patient's medical team

- First transplant of a planned tandem procedure (the second transplant is eligible)

Other exclusion criteria may apply.

Research Study Number       2659.00
Contact       Seattle Cancer Care Alliance Intake Office
Telephone       800-804-8824 / 206-288-1024

Acute Lymphoid Leukemia (ALL); Hematologic Malignancies

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Subscribe to an RSS feed of all trials

Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect and treat cancer and other life-threatening diseases.